New Zealand markets open in 3 hours 43 minutes

REGN May 2024 765.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.38000.0000 (0.00%)
As of 03:56PM EDT. Market open.
Full screen
Previous close2.3800
Open3.8000
Bid2.6500
Ask6.7000
Strike765.00
Expiry date2024-05-17
Day's range2.0600 - 3.8000
Contract rangeN/A
Volume6
Open interest6
  • Zacks

    Why Regeneron (REGN) Could Beat Earnings Estimates Again

    Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Reuters

    UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation

    Regeneron Pharmaceuticals said on Monday it seeks to defend against U.S. Department of Justice's complaint that alleged the company misreported the average sales price of its macular degeneration drug Eylea. "Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA's price," Regeneron said in a statement, adding that it considered the complaint to be "meritless". The DOJ last week, in a complaint filed in federal court in Boston, alleged the drugmaker failed for years to report how it paid hundreds of millions of dollars to subsidize Eylea purchases by reimbursing drug distributors for credit-card processing fees.

  • Reuters

    Regeneron to defend against DOJ complaint on drug-price manipulation

    "Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA's price," Regeneron said in a statement, adding that it considered the complaint to be "meritless". The DOJ last week, in a complaint filed in federal court in Boston, alleged the drugmaker failed for years to report how it paid hundreds of millions of dollars to subsidize Eylea purchases by reimbursing drug distributors for credit-card processing fees.